Table 2: Gender and primary diagnosis counts and percentages.
|
Project Groups |
|
Variable Category |
Pre-implementation group |
Post-implementation group |
Gender |
||
Female |
73 (57.9%) |
55 (50.9%) |
Male |
53 (42.1%) |
53 (49.1%) |
Primary Diagnosis |
||
Acute Pain |
3 (2.4%) |
1 (0.9%) |
Ambulatory Dysfunction |
2 (1.6)% |
3 (2.8%) |
Benign neoplasm |
1 (0.8%) |
4 (3.7%) |
Bowel Obstruction |
9 (7.1%) |
5 (4.6%) |
Cardiovascular Disease |
2 (1.6%) |
4 (3.7%) |
Cholecystitis |
2 (1.6%) |
3 (2.8%) |
Cirrhosis |
0 (0%) |
1 (0.9%) |
Electrolyte Disturbance |
4 (3.2%) |
1 (0.9%) |
Fracture |
37 (29.4%) |
27 (25%) |
Gastrointestinal Hemorrhage |
3 (2.4%) |
8 (7.4%) |
Malignant Neoplasm |
3 (2.4%) |
4 (3.7%) |
Osteoarthritis |
19 (15.1%) |
17 (15.7%) |
Pancreatitis |
2 (1.6%) |
2 (1.9%) |
Procedural Complications |
2 (1.6%) |
2 (1.9%) |
Renal Failure |
10 (7.9%) |
8 (7.4%) |
Respiratory failure |
3 (2.4%) |
4 (3.7%) |
Sepsis/Infection |
22 (17.5%) |
13 (12.0%) |
Syncope |
2 (1.6%) |
1 (0.9%) |